The global biopharma market continues to expand and is predicted to continue doing so for many years to come. A review of recent financial and biopharma press coverage indicates that mergers and acquisitions remain prevalent within this industry. More
This article considers the potential impact for the international pharmaceutical and biotechnology industries of decisions from a US and a UK court given within a week of each other in October 2004. More
Recently enacted changes to pharmaceutical law in Japan provide significant opportunities for non-Japanese companies to increase their market presence in the country and provide manufacturing services to its pharmaceutical industry More
More law firms than ever before are now targeting the life sciences industry, and those with traditional ties appear to be approaching the sector with renewed vigour. More
Concern among European fine chemicals companies over the large volume of illicit active pharmaceutical ingredients (APIs) imported into the European Union (EU) should be dampened by stricter EU regulations on the licensing of medicines. More
Judging by some of the more pessimistic coverage, the enlargement of the European Union (EU) will open the gates to a flood of cheap imports from accession countries to existing member states. More
The introduction of a single EU-wide patent, with a single enforcement system, has been the subject of debate for more than 30 years. Now, at last, it looks like becoming a reality. More
Displaying 1..10 of 31 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
